S&P Futures
3,836.00-10.00(-0.26%)Dow Futures
30,987.00-95.00(-0.31%)Nasdaq Futures
13,353.00-42.50(-0.32%)
Concord Medical Services Holdings Limited (CCM)
Chart Events
Performance Outlook
| Previous Close | 3.4400 |
| Open | 3.5000 |
| Bid | 3.6700 x 1200 |
| Ask | 3.7800 x 800 |
| Day's Range | 3.3800 - 3.7000 |
| 52 Week Range | 1.1300 - 5.8900 |
| Volume | 83,433 |
| Avg. Volume | 205,164 |
| Market Cap | 160.632M |
| Beta (5Y Monthly) | 0.35 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.0910 |
| Earnings Date | Jan 25, 2021 - Feb 01, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Dec 23, 2015 |
| 1y Target Est | N/A |
- PR Newswire
Concord Medical Announces Divestment of Singapore Concord International Hospital
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centers in China, today announced that the Company has, through its subsidiaries, entered into a definitive agreement to sell 90% equity interest in Concord Healthcare Singapore Pte Ltd, which operates and owns a general medical and surgical hospital, namely Concord International Hospital ("CIH"), for a total consideration of approximately SG$52.2 million. The purchasers have taken over the management of CIH and Concord Medical has ceased control over the management of CIH since the closing date in November 2020. Concord Medical has requested the purchasers to complete the renaming of CIH within the next six months or sooner. Concord Medical's board of directors believes the transaction price reflects the fair market value of CIH based on a valuation report by an independent third-party appraisal company engaged by the Company.
- PR Newswire
Concord Medical Schedules 2020 Annual Meeting of Shareholders
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centers in China, today announced that it will hold its 2020 annual general meeting of shareholders on December 21, 2020, at 10:00 a.m. (Beijing Time). The meeting will be held at 27/F, Tower A, Global Trade Center, 36 North 3rd Ring Road East, Dongcheng District, Beijing, China. The shareholder record date is December 1, 2020. No proposal will be submitted for shareholder approval at the annual general meeting. Instead, the annual general meeting will be convened for shareholders who are entitled to vote to discuss Company affairs with management. Concord Medical's annual report on Form 20-F filed with the U.S. Securities and Exchange Commission, containing the Company's audited financial statements for the financial year ended December 31, 2019, is available in the Investor Relations section of the Company's website at http://ir.ccm.cn. The Form 20-F is also available on the SEC's website at http://www.sec.gov.
- PR Newswire
Concord Medical Announces a Hoisting Ceremony for the Proton Therapy System of Guangzhou Concord Cancer Center
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centers in China, today announced that the hoisting ceremony for the proton therapy system of Guangzhou Concord Cancer Center (the "Center") was held at the construction site on September 30, 2020.
